Literature DB >> 14726656

Overexpression of E2F-1 in lung and liver metastases of human colon cancer is associated with gene amplification.

Marian Iwamoto1, Debabrata Banerjee, Lata G Menon, Anna Jurkiewicz, Pulivarthi H Rao, Nancy E Kemeny, Yuman Fong, Suresh C Jhanwar, Richard Gorlick, Joseph R Bertino.   

Abstract

We have shown previously that metastatic tumors of human colorectal cancer in lung as compared to liver have high levels of thymidylate synthase (TS) mRNA expression that correlated with high levels of E2F-1 mRNA expression. We now report that Comparative Genomic Hybridization (CGH) and DNA PCR analyses of lung and liver metastases of human colon cancer show frequent gains in the region of chromosome 20q and have an increase in gene copy number of E2F-1. In as much as TS is transcriptionally regulated by E2F-1, these results provide an explanation for the high levels of TS mRNA noted in some tumor samples.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726656

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  21 in total

1.  Deregulation of Rb-E2F1 axis causes chromosomal instability by engaging the transactivation function of Cdc20-anaphase-promoting complex/cyclosome.

Authors:  Somsubhra Nath; Abhishek Chowdhury; Sanjib Dey; Anirban Roychoudhury; Abira Ganguly; Dibyendu Bhattacharyya; Susanta Roychoudhury
Journal:  Mol Cell Biol       Date:  2014-11-03       Impact factor: 4.272

2.  Genomic and genetic variation in E2F transcription factor-1 in men with nonobstructive azoospermia.

Authors:  Carolina J Jorgez; Nathan Wilken; Josephine B Addai; Justin Newberg; Hima V Vangapandu; Alexander W Pastuszak; Sarmistha Mukherjee; Jill A Rosenfeld; Larry I Lipshultz; Dolores J Lamb
Journal:  Fertil Steril       Date:  2014-10-24       Impact factor: 7.329

3.  Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression.

Authors:  Long Chen; Tingyi Wei; Xiaoxing Si; Qianqian Wang; Yan Li; Ye Leng; Anmei Deng; Jie Chen; Guiying Wang; Songcheng Zhu; Jiuhong Kang
Journal:  J Biol Chem       Date:  2013-03-29       Impact factor: 5.157

4.  Largazole Arrests Cell Cycle at G1 Phase and Triggers Proteasomal Degradation of E2F1 in Lung Cancer Cells.

Authors:  Li-Chuan Wu; Zhe-Sheng Wen; Ya-Tao Qiu; Xiao-Qin Chen; Hao-Bin Chen; Ming-Ming Wei; Zi Liu; Sheng Jiang; Guang-Biao Zhou
Journal:  ACS Med Chem Lett       Date:  2013-08-12       Impact factor: 4.345

5.  E2F activators signal and maintain centrosome amplification in breast cancer cells.

Authors:  Mi-Young Lee; Carlos S Moreno; Harold I Saavedra
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

6.  Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer.

Authors:  Xiaoqi Xie; John E Kerrigan; Tamara Minko; Olga Garbuzenko; Kuo-Chieh Lee; Alex Scarborough; Emine Ercikan Abali; Tulin Budak-Alpdogan; Nadine Johnson-Farley; Debabrata Banerjee; Kathleen W Scotto; Joseph R Bertino
Journal:  Cancer Biol Ther       Date:  2013-06-03       Impact factor: 4.742

7.  E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma.

Authors:  Marina Palaiologou; John Koskinas; Menelaos Karanikolas; Evangelia Fatourou; Dina G Tiniakos
Journal:  Virchows Arch       Date:  2012-03-27       Impact factor: 4.064

8.  Loss of the eukaryotic initiation factor 3f in melanoma.

Authors:  Adriana Doldan; Anupama Chandramouli; Reneé Shanas; Achyut Bhattacharyya; Stanley P L Leong; Mark A Nelson; Jiaqi Shi
Journal:  Mol Carcinog       Date:  2008-10       Impact factor: 4.784

9.  Loss of the eukaryotic initiation factor 3f in pancreatic cancer.

Authors:  Adriana Doldan; Anupama Chandramouli; Reneé Shanas; Achyut Bhattacharyya; John T Cunningham; Mark A Nelson; Jiaqi Shi
Journal:  Mol Carcinog       Date:  2008-03       Impact factor: 4.784

10.  Overexpression of E2F1 promotes tumor malignancy and correlates with TNM stages in clear cell renal cell carcinoma.

Authors:  Xin Ma; Yu Gao; Yang Fan; Dong Ni; Yu Zhang; Weihao Chen; Peng Zhang; Erlin Song; Qingbo Huang; Qing Ai; Hongzhao Li; Baojun Wang; Tao Zheng; Taoping Shi; Xu Zhang
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.